OncoSec Medical CEO Daniel O'Connor's 2018 pay falls 39% to $4.2M

OncoSec Medical reports 2018 executive compensation

Published: November 8, 2018

OncoSec Medical reported fiscal year 2018 executive compensation information on November 8, 2018.

In 2018, four executives at OncoSec Medical received on average a compensation package of $2.2M, a 202% increase compared to previous year.

Average pay of disclosed executives at OncoSec Medical

Daniel J. O'Connor, Chief Executive Officer, received $4.2M in total. 91.11% of O'Connor's compensation, or $3.8M, was in option awards. O'Connor also received $70.1K in bonus, $283.1K in salary, as well as $19.4K in other compensation.

Punit Dhillon, Chief Executive Officer, received a compensation package of $2.7M, which increased by 234% compared to previous year. 36.72% of the compensation package, or $982.3K, was in other compensation.

Sara Bonstein, Chief Financial Officer, earned $919.2K in 2018.

Richard Slansky, Chief Financial Officer, received $915K in 2018, which increases by 76% compared to 2017.

OncoSec Medical's fiscal year ends on July 31.